Interaction between iNOS and COX-2 in hypoxia-induced retinal Neovascularization in mice

被引:27
作者
He, Tao [1 ]
Xing, Yi-Qiao [1 ]
Zhao, Xiao-Hui [1 ]
Ai, Ming [1 ]
机构
[1] Wuhan Univ, Dept Ophthalmol, Renmin Hosp, Wuhan 430060, Peoples R China
关键词
COX-2; iNOS; MMP-2; retinal neovascularization;
D O I
10.1016/j.arcmed.2007.05.003
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Upregulation of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) has been reported in hypoxia-induced retinal angiogenesis. The aim of our study was to evaluate the possible interaction between the COX and NOS pathways and the effect of this interaction on matrix metalloproteinases 2 (MMP-2) and vascular endothelial growth factor (VEGF) expression and on retinal angiogenesis. Methods. In this study, the effect of COX-2 or iNOS inhibition on retinal angiogenesis was examined by histopathology. Expression of iNOS, COX-2, MMP-2, and VEGF in the retinas of experimental animals was analyzed using immunohistochemistry, real-time PCR, and Western blotting technologies. Results. Inhibition of COX-2 or iNOS attenuated retinal neovascularization and decreased VEGF and MMP-2 expression. An interaction was found between COX-2 and iNOS expression: the iNOS inhibition decreased COX-2 expression and vice versa. Conclusions. Our data showed a prominent role of COX-2 and iNOS in hypoxia-induced retinal angiogenesis. The interaction between COX-2 and iNOS is likely to produce a cooperative effect on retinal angiogenesis. The changes of MMP-2 and VEGF expression may play a role in the process of retinal neovascularization. (c) 2007 IMSS. Published by Elsevier Inc.
引用
收藏
页码:807 / 815
页数:9
相关论文
共 25 条
  • [11] MODULATION OF THE INDUCTION OF NITRIC-OXIDE SYNTHASE BY EICOSANOIDS IN THE MURINE MACROPHAGE CELL-LINE J774
    MAROTTA, P
    SAUTEBIN, L
    DIROSA, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (03) : 640 - 641
  • [12] METALLOPROTEINASES AND THEIR INHIBITORS IN MATRIX REMODELING
    MATRISIAN, LM
    [J]. TRENDS IN GENETICS, 1990, 6 (04) : 121 - 125
  • [13] NITRIC-OXIDE SYNTHASES - ROLES, TOLLS, AND CONTROLS
    NATHAN, C
    XIE, QW
    [J]. CELL, 1994, 78 (06) : 915 - 918
  • [14] Hypoxia induces the expression of membrane-type 1 matrix metalloproteinase in retinal glial cells
    Noda, K
    Ishida, S
    Shinoda, H
    Koto, T
    Aoki, T
    Tsubota, K
    Oguchi, Y
    Okada, Y
    Ikeda, E
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (10) : 3817 - 3824
  • [15] The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2
    Notoya, K
    Jovanovic, DV
    Reboul, P
    Martel-Pelletier, J
    Mineau, F
    Pelletier, JP
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (06) : 3402 - 3410
  • [16] The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use
    O'Brien, TP
    Li, QJ
    Sauerburger, F
    Reviglio, VE
    Rana, T
    Ashraf, MF
    [J]. OPHTHALMOLOGY, 2001, 108 (04) : 656 - 659
  • [17] Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration
    Plantner, JJ
    Jiang, C
    Smine, A
    [J]. EXPERIMENTAL EYE RESEARCH, 1998, 67 (06) : 637 - 645
  • [18] Positive and negative regulation of NF-κB by COX-2-Roles of different prostaglandins
    Poligone, B
    Baldwin, AS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) : 38658 - 38664
  • [19] Low-density lipoprotein receptor-related protein-1 (LRP-1) expression in a rat model of oxygen-induced retinal neovascularization
    Sanchez, Maria C.
    Barcelona, Pablo F.
    Luna, Jose D.
    Ortiz, Susana G.
    Juarez, Patricio C.
    Riera, Clelia M.
    Chiabrando, Gustavo A.
    [J]. EXPERIMENTAL EYE RESEARCH, 2006, 83 (06) : 1378 - 1385
  • [20] Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy
    Sennlaub, F
    Courtois, Y
    Goureau, O
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (06) : 717 - 725